SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-000178
Filing Date
2024-01-23
Accepted
2024-01-23 16:09:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 schedule13ga.htm SC 13G/A 58039
  Complete submission text file 0000929638-24-000178.txt   59632
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-88939 | Film No.: 24552577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 104 FIELD POINT ROAD FLOOR 2 GREENWICH CT 06830
Business Address 104 FIELD POINT ROAD FLOOR 2 GREENWICH CT 06830 203-542-5527
Soleus Capital, LLC (Filed by) CIK: 0001786724 (see all company filings)

IRS No.: 364882601 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A